Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Lundbeck presents positive Phase IIb data for bocunebart (Lu AG09222; anti-PACAP mAb) in migraine prevention at the AHS congress

· The intravenous part of the Phase IIb clinical dose-finding trial PROCEED met its primary endpoint, with bocunebart demonstrating a statistically significant reduction in monthly migraine days versus placebo over Weeks 1–12 in patients with one to four prior preventive treatment failures · Bocunebart was generally well tolerated, with no new safety signals identified · The totality of the presented clinical data from the bocunebart Phase I-IIb program strengthens the evidence for PACAP pathway inhibition as a novel therapeutic approach for people severely impacted by migraine

Repurchase of shares in Bravida 28 May–4 June 2026

The Board of Directors of Bravida Holding AB (publ) ("Bravida") (LEI code:549300H88IJG­PNNL3T61) has, as communicated on 4 May 2026, initiated a share buyback program of maximum SEK 100 million. The purpose of the program is to optimize the company's capital structure and contribute to increased shareholder value. During the period from 28 May up to and including 4 June 2026, a total of 195,964 ordinary shares (ISIN: SE0007491303) were repurchased.Pursuant to the authorization granted by the 2026 Annual General Meeting, Bravida's Board of Directors has initiated a share buyback program of

Safello enters into strategic partnership agreement with Wictor Family Office, entailing a share subscription right in Safello

Stockholm, 4 June 2026 | Safello, the leading crypto exchange in the Nordics, announces that Safello Group AB (“Safello Group”) and its wholly owned subsidiary Safello AB has entered into a strategic partnership agreement with Wictor Family Office AB (“WFO”) and Wictor Holding AB (“Wictor Holding”) in relation to crypto assets services, which also grants a right for Wictor Holding to, on certain conditions, subscribe for shares in Safello Group.The partnership agreement is entered into in order to establish a strategic collaboration relating to custody of crypto assets and financial

The Board of Directors of Episurf has resolved on an issue of Class B shares, convertibles and warrants as part of the consideration for the acquisition of property assets

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, ISRAEL, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, THE UNITED KINGDOM, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR DISCLOSURE WOULD BE IN VIOLATION OF APPLICABLE LAWS OR REQUIRE ADDITIONAL REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO THE SECTION "IMPORTANT INFORMATION" AT THE END OF THIS PRESS RELEASE. The Board of Directors of Episurf Medical AB (publ) ("Episurf" or

Hexagon Composites ASA: Mandatory notification of trade

4 June 2026: Reference is made to the private placement announced by Hexagon Composites ASA (the "Company") on 7 May 2026 (the "Private Placement"). Please find attached PDMR-forms related to the subscription of shares in the Private Placement by primary insiders of the Company.This information is subject to disclosure requirements pursuant to the EU Market Abuse Regulation article 19 (3) and the Norwegian Securities Trading Act section 5-12.

Issue of Equity Further to Exercise of Warrants

  Delta Gold Technologies plc Issue of Equity further to Exercise of Investor Warrants   04 June 2026 – Delta Gold Technologies PLC (“Delta” or the “Company”) (Aquis: DGQ / OTCQB: DGQTF / FRA: O2J ), a technology company developing intellectual property in the quantum computing (“QC”) sector, announces that is has issued 357,142 new ordinary shares at an exercise price of 50p per share pursuant to the exercise of Investor Warrants issued in connection with the Company's subscription fundraise completed in February 2026 and a further 200,000 new ordinary shares at an

Peptonic Medical AB announces a new date for the publication of its annual report

Peptonic Medical AB (publ) announces that the company has decided to postpone the publication of its annual report for the 2025 financial year.The previously announced publication date was 3 June 2026. The new publication date is 10 June 2026. The annual report will be published on the company’s website as soon as it is finalised. For further information, please contact: Daniel Rudeklint, Interim CEO, Peptonic Medical AB Email: daniel.rudeklint@peptonicmedical.se Telephone: +46 73 158 02 73 About Peptonic Medical AB Peptonic Medical AB (publ) is a Swedish medical

Additional conversion of convertible loan in Smoltek completed

This press release is an English version of the previously published Swedish version, which has interpretive precedence. Smoltek Nanotech Holding AB (publ) (“Smoltek” or “the Company”) announces that an additional portion of the convertible loan with a nominal amount of SEK 20 million, which was issued in accordance with a resolution from the extraordinary general meeting on January 9, 2025, has been converted into shares in the Company. The total amount converted amounts to approximately SEK 200,000. The conversion has been carried out in accordance with the established terms and

Director/PDMR Shareholding

  Delta Gold Technologies plc Director’s Dealings Delta Gold Technologies PLC (Aquis: DGQ / OTCQB: DGQTF) (the "Company" or "Delta") has been notified today that on 4 June 2026, Mark Burnett, a director of the Company, purchased 7,000 ordinary shares in the Company at a price of £1.44 per ordinary share.  As a result, Mr Burnett is now interested in a total of 3,327,031 shares representing 5.14% of the Company’s issued share capital. The relevant Persons Discharging Managerial Responsibilities Disclosure (“PDMR”) is included below. About Delta Gold Technologies

#26-202 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Photocure ASA to Acquire Vesica Health Inc., Strengthening Leadership in Bladder Cancer Diagnostics

Oslo, Norway – June 4, 2026 – Photocure ASA (OSE: PHO), a leader in bladder cancer diagnostics, today announced the signing and successful completion of its acquisition of Vesica Health, a U.S. established precision diagnostics company advancing AssureMDx, a urine-based molecular test for the early detection of bladder cancer, in a transaction designed to expand Photocure’s position across the bladder cancer care continuum.Transaction Highlights ·  USD 30.5M in total cash + stock transaction · Of which USD 3.0M equity investment made during Q1 2026. · Net consideration of

Director/PDMR Shareholding

  Delta Gold Technologies plc Director’s Dealings Delta Gold Technologies PLC (Aquis: DGQ / OTCQB: DGQTF) (the "Company" or "Delta") has been notified today that on 4 June 2026, Richard Michael Jones, a director of the Company, purchased 7,000 ordinary shares in the Company at a price of £1.35 per ordinary share.  As a result, Mr Jones is now interested in a total of 9,617,615 shares representing 14.87% of the Company’s issued share capital. The relevant Persons Discharging Managerial Responsibilities Disclosure (“PDMR”) is included below. About Delta Gold

2026 Winners of the AIEN Awards

New Orleans, June 4, 2026 -- The Association of International Energy Negotiators (AIEN) has announced the winners of its annual Awards, recognizing standout achievements across the global energy sector and celebrating the deals, projects, and individuals shaping the future of international energy negotiation.Held at the Jaxson on the River in New Orleans on 3 June, the awards highlighted accomplishments in five key categories: Deal of the Year, Discovery of the Year, Venture of the Year, Energy Transition Initiative of the Year, and CSR Campaign of the Year, recognizing achievements from

Extraordinary General Meeting of SIBS AB (publ)

The board of SIBS AB (publ) decided today to withdraw and put on hold the proposals to the Extraordinary General Meeting due to ongoing discussions regarding the terms and size of the ongoing rights issue.   For more information, please contact: Håkan Brown CFO, SIBS AB hb@sibs.se     The information was submitted for publication, through the contact personabove, at 15.55 CEST on 4 June 2026.SIBS was founded in 2016 and is today one of the world’s leading modularbuilding manufacturers. With an annual scalable capacity of up to around 6,000homes, or 12,000

Brödernas Group AB (publ) — Exercise of PIK Option for interest payment due in June 2026

June 4, 2026, 15.30 CET Brödernas Group AB (publ) (the "Company"), issuer of senior secured callable fixed rate bonds 2024/2029 with ISIN NO0013250597 (the "Bonds"), hereby announces that it has elected to exercise its PIK Option in respect of the interest payment due on 10 June 2026 in accordance with the terms and conditions for the Bonds (the "Terms and Conditions"). Pursuant to Clause 12.2.4 of the Terms and Conditions, the interest payment due on 10 June 2026 will be paid in kind by way of issuance of subsequent bonds (sw. efterföljande obligationer) pro rata to bondholders, in

Resolution of the Annual General Meeting of Geveko Holding AB (publ)

The Annual General Meeting of Geveko Holding AB (publ) was held on May 28, 2026The following resolutions were adopted: Geveko Holding AB (publ) (“Geveko” or the “Company”) held its Annual General Meeting on May 28, 2026. The Annual General Meeting resolved in accordance with the proposals presented: Adoption of financial statements The Meeting approved the Company’s income statement and balance sheet for the financial year ended December 31, 2025. Discharge from liability The Meeting resolved to discharge the members of the Board of Directors and the CEO from liability for

The Supply Gap No One Is Filling: How CHARBONE Is Building the UHP Industrial Gas Platform Big Players Won’t

CompanyCharbone CorporationTickerTSXV: CH | OTCQB: CHHYF | FSE: K47ListingsTSX Venture (Canada) | OTCQB (USA) | Frankfurt (Germany)Market cap~C$42millionShare priceC$0.145 (at time of publication)Market sizeThe global hydrogen market is poised for significant growth, with projections indicating a rise from USD 225.12 billion in 2025 to USD 312.90 billion by 2030, at a CAGR of 6.8%.IndustryClean UHP hydrogen production & industrial gases distributionWebsitehttps://www.charbone.com/ Sweden —June 4th 2026

There are no items matching the current filter
There are no more items matching the current filter
Back to top